The Effectiveness of Comic-based Learning Materials on Nursing Students' Knowledge, Attitudes, and Confidence in Dementia Care
NCT07922109, Not applicable, Not yet recruiting, Taipei Medical University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Effectiveness of Comic-based Learning Materials on Nursing Students' Knowledge, Attitudes, and Confidence in Dementia Care | ClinicalTrials.gov |
| NCT number | NCT07922109 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 84 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Taipei Medical University | ClinicalTrials.gov |
| Conditions | Dementia Care Education, Students, Nursing, Education, Nursing, Dementia, Health Knowledge, Attitudes, Practice | ClinicalTrials.gov |
| Interventions | Comic-Based Dementia Care Education, Text-Based Dementia Care Education | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Dementia Knowledge Assessed by the DKAS-TC | Baseline, immediately after the intervention, and one month after the intervention. | Dementia knowledge will be assessed using the Traditional Chinese version of the Dementia Knowledge Assessment Scale (DKAS-TC). The scale consists of 25 items covering causes and characteristics, communication and behavior, care considerations, and risks and health promotion. A partial-credit scoring system is used, with each item scored from 0 to 2. Total scores range from 0 to 50, with higher scores indicating greater dementia knowledge. | ClinicalTrials.gov |
| Primary | Attitudes Toward Dementia Assessed by the DAS-C | Baseline, immediately after the intervention, and one month after the intervention. | Attitudes toward dementia will be assessed using the Chinese version of the Dementia Attitudes Scale (DAS-C). The scale consists of 17 items rated on a five-point Likert scale, including three reverse-scored items. Total scores range from 17 to 85, with higher scores indicating more positive attitudes toward people living with dementia. | ClinicalTrials.gov |
| Primary | Confidence in Dementia Care Assessed by the CODE-TW | Baseline, immediately after the intervention, and one month after the intervention. | Confidence in dementia care will be assessed using the Taiwanese version of the Confidence in Dementia Scale (CODE-TW). The scale consists of 9 items rated on a five-point Likert scale, assessing confidence in recognizing and understanding dementia, communication and interaction, and care management. Total scores range from 9 to 45, with higher scores indicating greater confidence in dementia care. | ClinicalTrials.gov |
| Secondary | Learning Materials Satisfaction | Immediately after the 60-minute educational intervention. Measure Description | Learning materials satisfaction will be assessed using a 10-item questionnaire developed by Chao et al. (2021). Each item is rated on a five-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 10 to 50, with higher scores indicating greater satisfaction with the assigned educational materials. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)